Rising prevalence of chronic diseases, stringent government regulations and safety guidelines and increasing awareness of needlestick injuries are the major factors which drive the global market ...
PRINCETON, NJ / ACCESSWIRE / September 24, 2024 / Enalare Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to developing novel compounds for the treatment of life-threatening ...
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be prescribed before purchase.